“Pain makes man think. Thought makes man wise. Wisdom makes life endurable.â€
-John Patrick, Tea House of the August Moon
There are few things in life more satisfying than the exhilarating thrill of discovery. Investing in ribonucleic acid ((RNA)) biotechnology does have its moments, despite a few notable, recent shareholder disappointments. RNA therapeutics in the last year have created a lot of excitement now evident in the investment world. With a solid research foundation established for understanding and elucidating various endogenous regulatory mechanisms, RNA mimetic drugs designed to correct biological dysfunction are moving forward in